Bordeaux Neurocampus > Publications scientifiques > Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy.

Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy.

M Maes
Neuropsychopharmacology. 2001-02-01; 24(2): 130-140
DOI: 10.1016/s0893-133x(00)00168-8

PubMed
Lire sur PubMed

Auteurs Bordeaux Neurocampus

février 1, 2001